Hydromorphone sustained-release (ER)

hydromorphone · Janssen Pharmaceutica N.V.

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for Hydromorphone sustained-release (ER), covering 2012-12-24 to 2012-12-24. Get the full timeline:

Most recent: Clinical Trial Update: A Study of the Effectiveness and Safety of Sustained-release Hydromorphone (a Strong Opioid) in Patients With Chronic Noncancer Pain. [Phase 3]

See pricing